Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Regan, Christopher P ^a   Anderson, Peter G ^a   Bishop, Sanford P ^a   Berecek, Kathleen H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

angiotensin II; angiotensin converting enzyme; hypertension; renin angiotensin system

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; FIBROSIS; HEART HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 33750726810     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.3.h906     Document Type: Article

References (31)

1. Anderson, P. G., S. P. Bishop, and S. B. Digerness. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ. Res. 64: 1127-1136, 1989.
2. Anderson, P. G., S. B. Digerness, J. L. Sklar, and P. J. Boor. Use of the isolated perfused heart for evaluation of cardiac toxicity. Toxicol. Pathol. 18: 497-509, 1990.
3. Baker, K., M. I. Chernin, S. K. Wixson, and J. F. Aceto. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H324-H332, 1990.
4. Berk, B. C., V. Vekshtein, H. M. Gordon, and T. Tsuda. Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension Dallas 13: 305-314, 1989.
5. Brilla, C. G., J. S. Janicki, and K. T. Weber. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ. Res. 69: 107-115, 1991.
6. Brilla, C. G., B. Maisch, and K. T. Weber. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. J. Clin. Invest. 71: S35-S41, 1993.
7. Brilla, C. G., L. S. Matsubara, and K. T. Weber. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J. Mol. Cell. Cardiol. 25: 563-575, 1993.
8. Brilla, C. G., R. Pick, L. B. Tan, J. S. Janicki, and K. T. Weber. Remodeling of the rat right and left ventricles in experimental hypertension. Circ. Res. 67: 1355-1364, 1990.
9. Clozel, J. P., H. Kuhn, and F. Hefti. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J. Hypertens. 7: 267-275, 1989.
10. Crawford, D. C., A. V. Chobanian, and P. Brecher. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 74: 727-739, 1994.
11. Gohlke, P., W. Linz, B. A. Scholkens, I. Kuiver, S. Bartenbach, A. Schnell, and T. Unger. Angiotensin converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension Dallas 23: 411-418, 1994.
12. Gosse, P., J. Grellet, S. Bonoron, L. Tariosse, P. Besse, and M. Dallocchio. Effects of perindopril on left ventricular hypertrophy, coronary blood flow, and mechanical properties of cardiac muscle in renovascular hypertensive rats. Am. J. Hypertens. 4: 235S-239S, 1991.
13. Kromer, E. P., and G. Riegger. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am. J. Cardiol. 62: 161-163, 1988.
14. Levy, D. L., R. J. Garrison, D. D. Savage, W. B. Kannel, and W. P. Castelli. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med. 322: 1561-1566, 1990.
15. Linz, W., J. Sehaper, G. Wiener, U. Albus, and B. A. Scholkens. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br. J. Pharmacol. 107: 970-975, 1992.
16. Linz, W., B. A. Scholkens, and D. Ganten. Converting enzyme inhibition specifically prevents the development and induces the regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. 11: 1325-1350, 1989.
17. 1 receptor antagonist, and surgical reversal. J. Cardiovasc. Pharmacol. 23: 291-299, 1994.
18. Nagano, M., J. Higaki, H. Mikami, M. Nakamuru, K. Higashimori, K. Katahina, Y. Tabuchi, A. Moriguchi, P. Nakamura, and T. Ogihara. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J. Hypertens. 9: 595-599, 1991.
19. Owens, G. K. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension Dallas 9: 178-187, 1987.
20. Reddy, H. K., S. Campbell, J. S. Janicki, G. Zhou, and K. T. Weber. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension. J. Lab. Clin. Med. 121: 510-521, 1993.
21. Ruzicka, M., B. Yuan, E. Harmsen, and F. Leenen. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Circulation 87: 921-930, 1993.
22. Sadoshima, J., Y. Xu, H. S. Slayter, and S. Izumo. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
23. Schelling, P., H. Fischer, and D. Ganten. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J. Hypertens. 9: 3-15, 1991.
24. Strauer, B. E. Structural and functional adaptation of the chronically overloaded heart in arterial hypertension. Am. Heart J. 114: 948-957, 1987.
25. Strauer, B. E. The concept of coronary flow reserve. J. Cardiovasc. Pharmacol 19, Suppl. 5: S67-S80, 1992.
26. Strauer, B. E., B. Schawrtzkopff, W. Motz, and M. Vogt. Coronary vascular changes in the progression and regression of hypertensive heart disease. J. Cardiovasc. Pharmacol. 18, Suppl. 3: S20-S27, 1991.
27. Urata, H., B. Healy, R. W. Stewart, F. M. Bumpus, and A. Husain. Angiotensin II-forming pathway in the normal and failing human hearts. Circ. Res. 66: 883-890, 1990.
28. Villarreal, F. J., N. Kim, G. Ungab, M. P. Printz, and W. H. Dillmann. Identification of functional angiotensin. II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
29. Weber, K. T., and C. G. Brilla. Pathological hypertrophy and cardiac interstitium: fibrosis and the renin-angiotensin-aldosterone system. Circulation 83: 1847-1865, 1991.
30. Weber, K. T., J. E. Jalil, J. S. Janicki, and R. Pick. Myocardial collagen remodeling in pressure overload hypertrophy: a case for interstitial heart disease. Am. J. Hypertens. 2: 931-940, 1989.
31. Zierhut, W., H. G. Zimmer, and A. M. Gerdes. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy. Circ. Res. 69: 609-617, 1991.